Literature DB >> 29411178

Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany".

Afschin Gandjour1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29411178     DOI: 10.1007/s10198-018-0957-3

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


× No keyword cloud information.
  2 in total

1.  Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.

Authors:  Alexander Kuhlmann; J-Matthias Graf von der Schulenburg
Journal:  Eur J Health Econ       Date:  2016-02-23

2.  Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.

Authors:  Louis P Garrison; Edward C Mansley; Thomas A Abbott; Brian W Bresnahan; Joel W Hay; James Smeeding
Journal:  Value Health       Date:  2009-10-23       Impact factor: 5.725

  2 in total
  1 in total

1.  Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany".

Authors:  Alexander Kuhlmann; J-Matthias Graf von der Schulenburg
Journal:  Eur J Health Econ       Date:  2018-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.